you are here:

Jubilant Pharmova Ltd.

BSE: 530019 | NSE: JUBLPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE700A01033 | SECTOR: Pharmaceuticals

BSE Live

Sep 23, 16:00
619.90 0.10 (0.02%)
Volume
AVERAGE VOLUME
5-Day
15,424
10-Day
16,204
30-Day
28,121
10,172
  • Prev. Close

    619.80

  • Open Price

    629.60

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Sep 23, 15:59
617.50 -2.80 (-0.45%)
Volume
AVERAGE VOLUME
5-Day
229,324
10-Day
241,809
30-Day
285,536
134,863
  • Prev. Close

    620.30

  • Open Price

    625.00

  • Bid Price (Qty.)

    617.50 (202)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2020 2019 2018 2017 2016
Nine Months Results of Jubilant Pharmova (in Rs. Cr.) Dec '20 Dec '19 Dec '18 Dec '17 Dec '16  
Net Sales/Income from operations 2,323.27 2,316.58 2,541.94 2,309.41 1,740.64  
Other Operating Income 20.37 31.96 31.55 32.49 29.21  
Total Income From Operations 2,343.64 2,348.54 2,573.49 2,341.90 1,769.85  
EXPENDITURE  
Consumption of Raw Materials 1,151.60 1,256.01 1,446.33 1,175.67 852.96  
Purchase of Traded Goods 58.82 78.32 110.77 105.33 96.52  
Increase/Decrease in Stocks 45.90 -60.55 -33.90 -28.03 -36.46  
Power & Fuel 250.90 280.07 271.88 250.33 193.58  
Employees Cost 185.89 197.47 201.87 191.07 166.51  
Depreciation 88.97 77.60 64.38 61.84 61.32  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 278.64 319.95 311.66 272.68 261.65  
P/L Before Other Inc. , Int., Excpt. Items & Tax 282.92 199.67 200.50 313.01 173.77  
Other Income 34.08 90.54 73.17 38.32 41.83  
P/L Before Int., Excpt. Items & Tax 317.00 290.21 273.67 351.33 215.60  
Interest 89.70 100.03 96.63 102.42 131.42  
P/L Before Exceptional Items & Tax 227.30 190.18 177.04 248.91 84.18  
Exceptional Items -- -1.70 -- -- --  
P/L Before Tax 227.30 188.48 177.04 248.91 84.18  
Tax 47.98 -21.48 36.85 71.86 30.82  
P/L After Tax from Ordinary Activities 179.32 209.96 140.19 177.05 53.36  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 179.32 209.96 140.19 177.05 53.36  
Equity Share Capital 15.93 15.93 15.93 15.93 15.93  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 11.26 13.18 8.80 11.12 3.35  
Diluted EPS 11.26 13.18 8.80 11.12 3.35  
EPS After Extra Ordinary  
Basic EPS. 11.26 13.18 8.80 11.12 3.35  
Diluted EPS. 11.26 13.18 8.80 11.12 3.35  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited